DE69230641T2 - Inhibitoren der stickstoffoxidsynthese zur potenzierung der wirkung von blutdruckwirksamen mitteln bei gewissen hypotonikern - Google Patents

Inhibitoren der stickstoffoxidsynthese zur potenzierung der wirkung von blutdruckwirksamen mitteln bei gewissen hypotonikern

Info

Publication number
DE69230641T2
DE69230641T2 DE69230641T DE69230641T DE69230641T2 DE 69230641 T2 DE69230641 T2 DE 69230641T2 DE 69230641 T DE69230641 T DE 69230641T DE 69230641 T DE69230641 T DE 69230641T DE 69230641 T2 DE69230641 T2 DE 69230641T2
Authority
DE
Germany
Prior art keywords
alpha
treatment
arginine
nitric oxide
inhibitor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69230641T
Other languages
English (en)
Other versions
DE69230641D1 (de
Inventor
S Gross
G Kilbourn
Roberto Levi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cornell Research Foundation Inc
University of Texas System
Original Assignee
Cornell Research Foundation Inc
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Research Foundation Inc, University of Texas System filed Critical Cornell Research Foundation Inc
Application granted granted Critical
Publication of DE69230641D1 publication Critical patent/DE69230641D1/de
Publication of DE69230641T2 publication Critical patent/DE69230641T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/085—Angiotensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/223—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of alpha-aminoacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
DE69230641T 1991-07-01 1992-07-01 Inhibitoren der stickstoffoxidsynthese zur potenzierung der wirkung von blutdruckwirksamen mitteln bei gewissen hypotonikern Expired - Fee Related DE69230641T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/723,480 US5216025A (en) 1989-09-13 1991-07-01 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients
PCT/US1992/005570 WO1993000893A1 (en) 1991-07-01 1992-07-01 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients

Publications (2)

Publication Number Publication Date
DE69230641D1 DE69230641D1 (de) 2000-03-09
DE69230641T2 true DE69230641T2 (de) 2000-06-15

Family

ID=24906450

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69230641T Expired - Fee Related DE69230641T2 (de) 1991-07-01 1992-07-01 Inhibitoren der stickstoffoxidsynthese zur potenzierung der wirkung von blutdruckwirksamen mitteln bei gewissen hypotonikern

Country Status (8)

Country Link
US (1) US5216025A (de)
EP (1) EP0592557B1 (de)
JP (1) JPH06508849A (de)
AT (1) ATE189386T1 (de)
AU (1) AU659664B2 (de)
CA (1) CA2111345A1 (de)
DE (1) DE69230641T2 (de)
WO (1) WO1993000893A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395612A (en) * 1990-03-27 1995-03-07 Cornell Research Foundation, Inc. Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an α1 adrenergic agonist
US5286739A (en) * 1991-09-27 1994-02-15 Board Of Regents, University Of Texas System Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
US5877176A (en) * 1991-12-26 1999-03-02 Cornell Research Foundation, Inc. Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
US5296466A (en) * 1992-02-19 1994-03-22 Board Of Regents, The University Of Texas System Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
AU5040493A (en) * 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
US5585402A (en) * 1992-12-23 1996-12-17 Glaxo Wellcome Inc. Nitric oxide synthase inhibitors
US5436270A (en) * 1993-04-07 1995-07-25 National Science Council Method for protecting against endotoxin-induced shock
US5554638A (en) * 1993-05-24 1996-09-10 Duke University Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
GB9312204D0 (en) * 1993-06-14 1993-07-28 Zeneca Ltd Therapeutic composition
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
JPH09504028A (ja) * 1993-10-21 1997-04-22 ジー．ディー．サール アンド カンパニー 酸化窒素シンターゼ抑制剤として有用なアミジノ誘導体
US5364881A (en) * 1993-11-15 1994-11-15 The Medical College Of Wisconsin Research Foundation, Inc. S-alkyl-isothioureido-amino acids and use thereof
US5502050A (en) * 1993-11-29 1996-03-26 Cornell Research Foundation, Inc. Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
US5665757A (en) * 1994-07-13 1997-09-09 Robert W. Dunn Method for treating anxiety
US5519020A (en) * 1994-10-28 1996-05-21 The University Of Akron Polymeric wound healing accelerators
US5545625A (en) * 1994-12-12 1996-08-13 The Medical College Of Wisconsin Research Foundation, Inc. Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction
ES2096524B1 (es) * 1994-12-22 1997-11-16 Sanchez Manuel Guerra Uso de la ng-monometil-l-arginina, para aumentar la capacidad de hacer ejercicio fisico.
ES2206571T3 (es) * 1995-04-20 2004-05-16 G.D. SEARLE & CO. Agentes de amidino ciclico utiles como inhibidores de la oxido nitrico sintasa.
US5945408A (en) * 1996-03-06 1999-08-31 G.D. Searle & Co. Hydroxyanidino derivatives useful as nitric oxide synthase inhibitors
US5789395A (en) * 1996-08-30 1998-08-04 The Research Foundation Of State University Of New York Method of using tetracycline compounds for inhibition of endogenous nitric oxide production
US5981556A (en) * 1997-07-22 1999-11-09 G.D. Searle & Co. 1,3-diazolino and 1,3-diazolidino heterocycles as useful nitric oxide synthase inhibitors
US20020031513A1 (en) * 1997-11-24 2002-03-14 Shamir Leibovitz Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals
CA2333691A1 (en) 1998-06-10 1999-12-16 G.D. Searle & Co. Heterobicyclic and tricyclic nitric oxide synthase inhibitors
WO2001052902A1 (en) * 2000-01-24 2001-07-26 Isis Pharmaceuticals, Inc. Antisense modulation of inducible nitric oxide synthase expression
WO2001078717A1 (en) 2000-04-12 2001-10-25 Cornell Research Foundation, Inc. Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity
US6344473B1 (en) 2000-08-07 2002-02-05 G.D. Searle & Co. Imidazoles useful as nitric oxide synthase inhibitors
US9572856B2 (en) * 2009-12-16 2017-02-21 The George Washington University a Congressionally Chartered Not-for-Profit Corporation Method of treating low blood pressure
AU2014256944B2 (en) 2013-04-26 2019-06-27 La Jolla Pharma, Llc Compositions and methods for treating renal failure
SI2986308T1 (sl) 2013-12-18 2020-03-31 The George Washington University, A Congressionally Chartered Not-For-Profit Corporation Angiotenzin II v kombinaciji za zdravljenje hipotenzije
TW201733610A (zh) 2016-01-07 2017-10-01 拉荷亞製藥公司 投與血管收縮素ｉｉ之方法
WO2018191678A1 (en) 2017-04-14 2018-10-18 La Jolla Pharmaceutical Company Methods for administering angiotensin ii
US20220288164A1 (en) * 2019-08-20 2022-09-15 Georgetown University Method to increase systemic blood pressure in shock

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1127322B (it) * 1979-12-28 1986-05-21 Italfarmaco Spa Composizioni farmaceutiche con esaltazione dell'attivita' terapeutica di cortisonici
US4734438A (en) * 1983-04-26 1988-03-29 Macri Frank J Norepinephrine potentiated compositions and method of use
FR2637119A1 (fr) * 1988-09-23 1990-03-30 Thomson Csf Dispositif de commande manuelle par entrainement d'un bouton en rotation
DE3838461A1 (de) * 1988-11-12 1990-05-23 Krebsoege Gmbh Sintermetall Pulvermetallurgischer werkstoff auf kupferbasis und dessen verwendung
US5028627A (en) * 1989-09-13 1991-07-02 Cornell Research Foundation, Inc. Method of using arginine derivatives to inhibit systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5059712A (en) * 1989-09-13 1991-10-22 Cornell Research Foundation, Inc. Isolating aminoarginine and use to block nitric oxide formation in body

Also Published As

Publication number Publication date
AU2308092A (en) 1993-02-11
US5216025A (en) 1993-06-01
ATE189386T1 (de) 2000-02-15
EP0592557A1 (de) 1994-04-20
EP0592557B1 (de) 2000-02-02
EP0592557A4 (de) 1994-08-03
CA2111345A1 (en) 1993-01-21
JPH06508849A (ja) 1994-10-06
DE69230641D1 (de) 2000-03-09
WO1993000893A1 (en) 1993-01-21
AU659664B2 (en) 1995-05-25

Similar Documents

Publication Publication Date Title
DE69230641D1 (de) Inhibitoren der stickstoffoxidsynthese zur potenzierung der wirkung von blutdruckwirksamen mitteln bei gewissen hypotonikern
DE69034206D1 (de) Argininantagonisten zur Hemmung des systemischen Blutdruckes in Zusammenhang mitStickoxidbildung oder Endothelial Derived Relaxing Factor
NO924326L (no) Antitrombosemidler
EP0303465A3 (de) Phenethanolamin-Derivate
Borth et al. Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin.
UA26375A1 (uk) Спосіб очищеhhя іhсуліhу
SE9101838D0 (sv) Novel peptides and their use
KR910001068A (ko) 항생제
DK0804465T3 (da) Nye elastaseinhibitorer
DE69023006D1 (de) Verfahren zur behandlung von thrombocytopenie und dafür geeignete pharmazeutische zusammensetzungen.
NO894720L (no) Farmasoeytisk aktivt protein.
DE69637812D1 (de) Schützende Epitope von Adenylate-Zyklase-Hämolysin(AC-Hly) und ihre Verwendung zur Behandlung oder Verhütung von Bordetella-Infektionen
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
DE69834929D1 (de) Verwendung eines organspezifischen ernährungmittels
DK0609242T3 (da) Nyt thrombininhibitorisk protein fra blodmider
ES2097931T3 (es) Nueva proteina inhibidora de trombina a partir de chinches cazadoras.
DE68908958D1 (de) Peptide.
ES2123570T3 (es) Uso de la molecula de adhesion de leucocitos y endotelios 1 y anticuerpos contra ella en el tratamiento del asma.
ATE133860T1 (de) Tumor-nekrose-faktor-antagonist
RU94046312A (ru) Применение биологически активных уреидопроизводных для лечения индуцируемых лентивирусами заболеваний, продукты, содержащие уреидопроизводные
DE69306794T2 (de) Alkylamino-ethynyl-alanin-aminodiolverbindungen mit imidazolyl/benzimidazolyl-endgruppe zur behandlung von bluthochdruck
EP0391180A3 (de) Peptidartige Aminosäurederivate mit reninhemmender Wirkung
Brooks et al. Effect of secretin on gastric acid secretion stimulated by gastrin II, caerulein and desulfated caerulein
RU94026088A (ru) Способ лечения шока и способ ингибирования продуцирования альфа фактора некроза опухоли
DE69131248T2 (de) Inhibition der ausscheidung von natrium durch die na-k-atpase

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee